Ginkgo Bioworks DNA Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's common stock, shares issued (in shares)?
- Ginkgo Bioworks (DNA) reported common stock, shares issued (in shares) of $65.13M in Q1 2026.
- How has Ginkgo Bioworks's common stock, shares issued (in shares) changed year-over-year?
- Ginkgo Bioworks's common stock, shares issued (in shares) increased by 12.0% year-over-year, from $58.15M to $65.13M.
- What is the long-term trend for Ginkgo Bioworks's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's common stock, shares issued (in shares) has grown at a -45.6% compound annual growth rate (CAGR), from $1.29B to $61.68M.